<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9</volume><submitter>Li Y</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Quiescin Q6 sulfhydryl oxidase 2 (QSOX2), an enzyme that can be directly secreted into the extracellular space, is known to be associated with oxidative protein folding. However, whether &lt;i>QSOX2&lt;/i> is abnormally expressed in non-small cell lung cancer (NSCLC) and its role in tumor growth remains unclear.&lt;h4>Methods&lt;/h4>Real-time quantitative PCR (qPCR), immunohistochemistry (IHC), bioinformatics analyses were applied to analyze the expression pattern and prognostic significance of QSOX2 in NSCLC. Xenografts model, enzyme-linked immunosorbent assays (ELISA), western blot analysis (WB), and IHC were preformed to examine &lt;i>in vivo&lt;/i> tumor suppression and intracellular and extracellular expression of QSOX2. Flow cytometry, WB and qPCR analyses were used to elucidate the</pubmed_abstract><journal>Frontiers in cell and developmental biology</journal><pagination>688798</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8326667</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.</pubmed_title><pmcid>PMC8326667</pmcid><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Xiong J</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Liu M</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Shi C</pubmed_authors><pubmed_authors>Deng L</pubmed_authors><pubmed_authors>Zhai Z</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Zhang C</pubmed_authors></additional><is_claimable>false</is_claimable><name>QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.</name><description>&lt;h4>Background&lt;/h4>Quiescin Q6 sulfhydryl oxidase 2 (QSOX2), an enzyme that can be directly secreted into the extracellular space, is known to be associated with oxidative protein folding. However, whether &lt;i>QSOX2&lt;/i> is abnormally expressed in non-small cell lung cancer (NSCLC) and its role in tumor growth remains unclear.&lt;h4>Methods&lt;/h4>Real-time quantitative PCR (qPCR), immunohistochemistry (IHC), bioinformatics analyses were applied to analyze the expression pattern and prognostic significance of QSOX2 in NSCLC. Xenografts model, enzyme-linked immunosorbent assays (ELISA), western blot analysis (WB), and IHC were preformed to examine &lt;i>in vivo&lt;/i> tumor suppression and intracellular and extracellular expression of QSOX2. Flow cytometry, WB and qPCR analyses were used to elucidate the</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-05-08T12:39:19.916Z</modification><creation>2022-02-11T04:28:47.562Z</creation></dates><accession>S-EPMC8326667</accession><cross_references><pubmed>34350181</pubmed><doi>10.3389/fcell.2021.688798</doi></cross_references></HashMap>